Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Apr 30 2024

Full Issue

WHO Advisers Say Next Covid Vaccine Should Use Monovalent JN.1 Lineage

CIDRAP reports on the advisory group meeting earlier this month, where the experts predicted that in the near term, circulating variants of covid will likely be derived from JN.1. Also in the news about infectious disease: a covid booster's impact on odds of long covid; what we're learning about H5N1 bird flu virus infections in cows; and more.

CIDRAP: WHO COVID Vaccine Advisers Recommend Switch To JN.1 Strain 

The World Health Organization (WHO) Technical Advisory Group on COVID-19 Vaccine Composition, which meets about every 6 months to assess if any changes are needed, has recommended that the next COVID vaccine formulations use a monovalent (single-strain) JN.1 lineage. The group met in the middle of April to review the genetic and antigenic evolution of SARS-CoV-2, with an eye toward vaccine composition implications.  (Schnirring, 4/29)

CIDRAP: COVID Booster Linked To 25% Lower Odds Of Long COVID 

A new cross-sectional study published in Vaccine of US adults demonstrates that people who received the COVID-19 booster vaccine had 25% lower odds of having long COVID than their unvaccinated counterparts. (Soucheray, 4/29)

CIDRAP: X's Crowdsourced Tool To Counter COVID Untruths Mainly Accurate, Credible, Researchers Say 

Community Notes, a crowdsourced COVID-19 vaccine misinformation countermeasure on X (formerly Twitter), generally corrected false posts accurately and pointed readers to more credible sources, according to researchers who evaluated the posts. The University of California at San Diego (UCSD)-led team assessed the accuracy and credibility of a random sample of 205 Community Notes on COVID-19 vaccines from the year after the tool's December 2022 launch. The reviewers included an infectious-disease doctor and a virologist. The results were published last week in JAMA. (Van Beusekom, 4/29)

CBS News: Seller Of Fraudulent N95 Face Masks To Refund $1.1 Million To Customers

A company alleged to have fraudulently sold a face mask as N95-grade must refund more than $1.1 million to customers nationwide, the Federal Trade Commission announced Monday. Razer and its affiliates advertised the Zephyr mask as N95-grade despite never submitting it for testing or certification by the Food and Drug Administration or National Institute for Occupational Safety and Health, the agency said. (Gibson, 4/29)

AP: Chinese Scientist Who First Published COVID Sequence Protests After Being Locked Out Of His Lab 

he first scientist to publish a sequence of the COVID-19 virus in China was staging a sit-in protest after authorities locked him out of his lab. Virologist Zhang Yongzhen wrote in an online post Monday that he and his team had been suddenly notified they were being evicted from their lab, the latest in a series of setbacks, demotions and ousters since Zhang published the sequence in January 2020 without state approval. The move shows how the Chinese state continues to pressure and control scientists conducting research on the coronavirus. (Kang, 4/30)

On the spread of bird flu —

CIDRAP: Analysis Of Cow, Cat H5N1 Avian Flu Samples Raises Concerns About Spread To Other Animals 

Microbiological examination of cow, milk, and cat samples early in the investigation of H5N1 avian flu in some of the first affected states found that the cats died shortly after they were fed raw colostrum from sick cows, highlighting the risk of spread from cows to other animals through contaminated milk. (Schnirring, 4/29)

Stat: H5N1 Bird Flu: What We're Starting To Learn About Infection In Cows 

The H5N1 bird flu virus has been around for decades, and the damage it wreaks on chickens and other poultry is well documented. But the recent discovery that the virus has jumped into dairy cattle — whose udders seem to be where the virus either infects or migrates to — has dumbfounded scientists and agricultural authorities. (Branswell and Molteni, 4/30)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 22
  • Thursday, May 21
  • Wednesday, May 20
  • Tuesday, May 19
  • Monday, May 18
  • Friday, May 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF